T. Rowe Price Associates
ASMB icon

T. Rowe Price Associates’s Assembly Biosciences ASMB Stock Holding History

T. Rowe Price Associates’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-51,520
Closed -$10.2M – 2667
2020
Q3 		$10.2M Sell
51,520
-5,241
-9% -$1.32M ﹤0.01% 1298
2020
Q2 		$15.9M Sell
56,761
-4,665
-8% -$1.09M ﹤0.01% 1200
2020
Q1 		$10.9M Sell
61,426
-12,548
-17% -$2.69M ﹤0.01% 1217
2019
Q4 		$18.2M Buy
+73,974
New +$13.6M ﹤0.01% 1214
2018
Q4 		– Sell
-18,525
Closed -$8.26M – 2562
2018
Q3 		$8.26M Buy
18,525
+1,034
+6% +$484K ﹤0.01% 1404
2018
Q2 		$8.23M Buy
17,491
+2,535
+17% +$1.34M ﹤0.01% 1377
2018
Q1 		$8.82M Buy
+14,956
New +$9.27M ﹤0.01% 1360

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

T. Rowe Price Associates's ASMB Position: Q4 2020 in Review

T. Rowe Price Associates sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 51,520 shares — an estimated $10.2M sold.

T. Rowe Price Associates first reported a position in ASMB in Q1 2018 and held it in 7 quarters. The position peaked at $18.2M in Q4 2019. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • T. Rowe Price Associates reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • T. Rowe Price Associates sold 51,520 Assembly Biosciences shares in Q4 2020, an estimated $10.2M.
  • T. Rowe Price Associates first reported a position in Assembly Biosciences in Q1 2018 and held it in 7 quarters.
  • T. Rowe Price Associates's Assembly Biosciences position peaked at $18.2M in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on T. Rowe Price Associates's 13F filing for Q4 2020, filed 16 Feb 2021.